免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D

NCT:NCT07593625 · RECRUITING

NCT编号NCT07593625
状态RECRUITING
开始日期2026-05-25
完成时间2027-02-01
SponsorInsulet Corporation (INDUSTRY)
First posted
Last updated

简要摘要

Feasibility study to evaluate the safety and feasibility of Omnipod automated insulin delivery algorithms in individuals with type 1 diabetes. This study will enroll up to 80 participants to have a minimum of 48 participants to initiate the use of Omnipod. The study will include hotel and outpatient evaluation periods.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑